Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver? ; volume:11 ; number:10 ; day:27 ; month:8 ; year:2020 ; pages:2207-2219 ; date:10.2020
Diabetes therapy ; 11, Heft 10 (27.8.2020), 2207-2219, 10.2020
- Creator
-
Williams, David M.
Evans, Marc
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13300-020-00911-0
- URN
-
urn:nbn:de:101:1-2020110920553385975857
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Williams, David M.
- Evans, Marc
- SpringerLink (Online service)
Other Objects (12)
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
Stand and deliver!
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Deliver us from love
Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
Learn How We Deliver. Continuously.
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
Stand and deliver!
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Deliver us from love
Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
Learn How We Deliver. Continuously.
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
Stand and deliver!
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Deliver us from love
Dapagliflozin: A Review in Symptomatic Heart Failure with Reduced Ejection Fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review